Johan Svartberg

Author PubWeight™ 37.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 2009 2.01
2 Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 2012 1.87
3 Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J Clin Endocrinol Metab 2008 1.79
4 Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. J Hypertens 2005 1.75
5 Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study. Nutr Metab Cardiovasc Dis 2007 1.62
6 Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study. J Neurol 2005 1.49
7 Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels. Thromb Haemost 2009 1.42
8 Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study. J Clin Endocrinol Metab 2004 1.34
9 Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One 2012 1.23
10 Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. Eur J Endocrinol 2009 1.19
11 Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. Eur J Endocrinol 2009 1.19
12 Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol 2010 1.18
13 The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol 2013 1.13
14 Incidence of and risk factors for type-2 diabetes in a general population: the Tromsø Study. Scand J Public Health 2010 1.10
15 Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur J Endocrinol 2010 1.05
16 High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 2011 1.02
17 Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol 2008 0.98
18 Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromsø Study. Eur J Epidemiol 2010 0.97
19 Androgen receptor gene polymorphism and the metabolic syndrome in 60-80 years old Norwegian men. Int J Androl 2008 0.86
20 Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res Notes 2012 0.86
21 Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels. Scand J Clin Lab Invest 2008 0.85
22 Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. Eur J Endocrinol 2012 0.85
23 Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH. Int J Radiat Oncol Biol Phys 2008 0.84
24 Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control. Diabetes Care 2009 0.83
25 Testosterone levels and psychological health status in men from a general population: the Tromsø study. Aging Male 2010 0.83
26 Testosterone, hemostasis, and cardiovascular diseases in men. Semin Thromb Hemost 2011 0.81
27 Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure. Clin Endocrinol (Oxf) 2011 0.81
28 Associations between polymorphisms related to calcium metabolism and human height: the Tromsø Study. Ann Hum Genet 2012 0.80
29 Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels. Thromb Haemost 2009 0.79
30 Estrogen receptor alpha single nucleotide polymorphism as predictor of diabetes type 2 risk in hypogonadal men. Aging Male 2013 0.79
31 [Treatment practice in primary hyperparathyroidism]. Tidsskr Nor Laegeforen 2009 0.78
32 Effects of Age and Sex on Estimated Diabetes Prevalence Using Different Diagnostic Criteria: The Tromsø OGTT Study. Int J Endocrinol 2013 0.78
33 Postprandial triglyceride metabolism in elderly men with subnormal testosterone levels. Asian J Androl 2008 0.78
34 Androgen receptor gene polymorphism and sex hormones in elderly men: the Tromsø study. Asian J Androl 2009 0.77
35 Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study. Eur J Prev Cardiol 2011 0.76
36 [Endogenous Cushing's syndrome]. Tidsskr Nor Laegeforen 2006 0.75
37 [Hormonally inactive pituitary adenomas]. Tidsskr Nor Laegeforen 2003 0.75
38 The phosphodiesterase 8B gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: the Tromsø study. Thyroid 2013 0.75
39 [Primary adrenal failure--causes, diagnostics and therapy]. Tidsskr Nor Laegeforen 2005 0.75